Portola, part 1: the new drug application for betrixaban

Two readers emailed in to point out that I misinterpreted the meaning of the net clinical benefit figure. As much as I hate being wrong, I hate misleading people even more  – so I’ve pulled the piece until I get a chance to take another look at the data.

A word of thanks for the readers who wrote in with their disagreements.